Related Experiment Video
Updated: Jun 28, 2026
06:08
Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Proteomics blood testing to distinguish chronic rhinosinusitis subtypes
Subinoy Das1, Patricia A Maeso, Adam M Becker
1Department of Otolaryngology, Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA. subinoy.das@osumc.edu
The Laryngoscope
|November 4, 2008
Summary
Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) shows promise for distinguishing chronic rhinosinusitis subtypes. This proteomic profiling may lead to a rapid blood test for identifying severe forms of the condition.
Area of Science:
- Proteomics and Mass Spectrometry
- Immunology and Allergy
- Otolaryngology
Background:
- Chronic rhinosinusitis (CRS) encompasses heterogeneous subtypes, complicating diagnosis and treatment.
- Accurate differentiation of CRS subtypes, such as allergic fungal rhinosinusitis (AFRS) and Samter's triad, is clinically significant.
- Current diagnostic methods may not fully capture the molecular distinctions between CRS subtypes.
Purpose of the Study:
- To evaluate the efficacy of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) for serum proteomic profiling.
- To determine if SELDI-TOF-MS can differentiate between subtypes of chronic rhinosinusitis with nasal polyposis.
- To explore the potential of SELDI-TOF-MS as a diagnostic tool for identifying specific CRS subtypes.
Main Methods:
- A translational study involving serum samples from patients undergoing sinus surgery for CRS with nasal polyposis.
- SELDI-TOF-MS analysis was performed on 42 serum samples from patients diagnosed with AFRS, Samter's triad, or CRS with nasal polyposis.
- Classification tree analysis was applied to protein spectra (0-100 kD range) to identify distinguishing features for disease subtypes.
Main Results:
- In two-subtype comparisons, SELDI-TOF-MS achieved 84% sensitivity and 90% specificity for identifying AFRS, and 88% sensitivity and 88% specificity for Samter's triad.
- In three-subtype comparisons, SELDI-TOF-MS demonstrated 76% sensitivity and 82% specificity for AFRS, and 80% sensitivity and 90% specificity for Samter's triad.
- These findings indicate a high degree of accuracy in distinguishing between CRS subtypes using serum proteomic profiles.
Conclusions:
- The study provides molecular evidence supporting allergic fungal rhinosinusitis as a distinct subtype of chronic rhinosinusitis.
- SELDI-TOF-MS emerges as a promising technology for developing a rapid blood test to identify severe CRS subtypes.
- Further research is warranted to validate the clinical utility of SELDI-TOF-MS in CRS diagnosis and management.
